For research use only. Not for therapeutic Use.
JZP-110 hydrochloride (CAT: I009552) is a wake-promoting agent and stimulant used for the treatment of excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder. It is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) that increases the levels of these neurotransmitters in the brain, promoting wakefulness and reducing sleepiness. JZP-110 hydrochloride has shown efficacy in improving wakefulness and reducing sleep attacks in clinical studies. It is a promising option for individuals with sleep disorders who require increased wakefulness and improved daytime functioning.
| Catalog Number | I009552 |
| CAS Number | 178429-65-7 |
| Synonyms | R228060; R-228060; R 228060; JZP-110; ADX-N-05; ARL-N-05; R-228060; SKL-N-05; YKP-10A; ADXN-05; ARLN-05; SKLN-05; Solriamfetol. Solriamfetol hydrochloride.;(R)-2-amino-3-phenylpropyl carbamate hydrochloride |
| Molecular Formula | C10H15ClN2O2 |
| Purity | ≥95% |
| Solubility | Soluble in DMSO |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| Related CAS | 178429-62-4 (free base) |
| IUPAC Name | [(2R)-2-amino-3-phenylpropyl] carbamate;hydrochloride |
| InChI | InChI=1S/C10H14N2O2.ClH/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8;/h1-5,9H,6-7,11H2,(H2,12,13);1H/t9-;/m1./s1 |
| InChIKey | KAOVAAHCFNYXNJ-SBSPUUFOSA-N |
| SMILES | C1=CC=C(C=C1)CC(COC(=O)N)N.Cl |
| Reference | <p> |
